Company intelligence / Profile preview

Imagindairy

Tirat Carmel, Haifa District, Israelimagindairy.com ↗

Ownership: Private
Development stage: Commercial

Overview

Imagindairy has developed a proprietary precision fermentation platform to produce animal-free dairy proteins, achieving GRAS status from the FDA for its whey protein. The company has acquired industrial-scale manufacturing capacity and expects commercial product launches in the US market imminently. Its technology enables cost parity with traditional dairy while offering environmental and ethical benefits[7][9].

Modalities: Recombinant proteinFermentation-derived protein
Industry: Food & Nutrition

Partnerships

Danone’s corporate venture arm (“strategic collaboration projects”)

Beyond the preview

Go deeper on Imagindairy.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Imagindairy.

Explore the full profile